Mucocutaneous toxicity induced by pegylated liposomal doxorubicin: a single-institution, retrospective case series

Br J Dermatol. 2017 Feb;176(2):507-509. doi: 10.1111/bjd.14806. Epub 2016 Dec 27.

Authors

M Vaccaro¹, M Santarpia², G Calapai³, C Mannucci³, F Borgia¹, G Altavilla², S P Cannavò¹

Affiliations

¹ Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
² Medical Oncology Unit, Human Pathology Department, University of Messina, Messina, Italy.
³ Department of Biomedical, Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy.

PMID: 27291307
DOI: 10.1111/bjd.14806

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Antibiotics, Antineoplastic / administration & dosage
Antibiotics, Antineoplastic / adverse effects*
Dose-Response Relationship, Drug
Doxorubicin / administration & dosage
Doxorubicin / adverse effects
Doxorubicin / analogs & derivatives*
Drug Eruptions / etiology*
Female
Humans
Male
Middle Aged
Neoplasm Recurrence, Local / drug therapy
Neoplasms / drug therapy*
Polyethylene Glycols / administration & dosage
Polyethylene Glycols / adverse effects
Retrospective Studies

Substances

Antibiotics, Antineoplastic
liposomal doxorubicin
Polyethylene Glycols
Doxorubicin